<DOC>
	<DOCNO>NCT01166516</DOCNO>
	<brief_summary>Study collect post-market safety data HUD IBV Valve System , device control prolong air leak lung , significant air leaks likely become prolong air leak follow lobectomy , segmentectomy , LVRS . An air leak present post-operative day 7 consider prolonged unless present force exhalation cough . An air leak present day 5 consider treatment : 1 ) continuous , 2 ) present normal inhalation phase inspiration , 3 ) present upon normal expiration accompany subcutaneous emphysema respiratory compromise .</brief_summary>
	<brief_title>IBV Valve System Treatment Prolonged Air Leak Under HDE H060002 - Post Approval Study</brief_title>
	<detailed_description />
	<criteria>Subject air leak present day 7 lobectomy , segmentectomy , lung volume reduction surgery ( LVRS ) , day 5 air leak 1 ) continuous , 2 ) present normal inhalation phase inspiration , 3 ) present upon normal expiration accompany subcutaneous emphysema respiratory compromise Air leak force exhalation cough Subject significant active asthma , pneumonia , bacterial bronchitis clinically significant bronchiectasis Subject unable provide inform consent designate authority sign incapacitate patient Subject appropriate candidate , unable tolerate , flexible bronchoscopy procedure Subject comorbidities factor prevent followup study period</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Prolonged air leak</keyword>
	<keyword>lobectomy</keyword>
	<keyword>segmentectomy</keyword>
	<keyword>lung volume reduction surgery ( LVRS )</keyword>
</DOC>